Markus Vallaster

866 total citations
14 papers, 696 citations indexed

About

Markus Vallaster is a scholar working on Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Markus Vallaster has authored 14 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Markus Vallaster's work include CAR-T cell therapy research (6 papers), Cardiac Fibrosis and Remodeling (3 papers) and Immunotherapy and Immune Responses (3 papers). Markus Vallaster is often cited by papers focused on CAR-T cell therapy research (6 papers), Cardiac Fibrosis and Remodeling (3 papers) and Immunotherapy and Immune Responses (3 papers). Markus Vallaster collaborates with scholars based in United States, Germany and Canada. Markus Vallaster's co-authors include Paul Gardner, Oliver J. Rando, Andrew R. Tapper, Hans Theiß, Stefan Brunner, Gerald Assmann, Josef Mueller‐Hoecker, Bruno Hüber, Marc‐Michael Zaruba and R Fischer and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Markus Vallaster

14 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Vallaster United States 7 339 166 165 145 140 14 696
Carolyn M. Macica United States 21 434 1.3× 152 0.9× 243 1.5× 135 0.9× 100 0.7× 33 1.2k
Irene Szijan Argentina 15 410 1.2× 103 0.6× 112 0.7× 74 0.5× 111 0.8× 59 749
Daisuke Kajimura United States 10 601 1.8× 80 0.5× 168 1.0× 99 0.7× 118 0.8× 12 1.1k
Ahmet Okay Çağlayan Türkiye 18 482 1.4× 115 0.7× 43 0.3× 119 0.8× 72 0.5× 79 1.1k
Mei Fang United States 7 615 1.8× 662 4.0× 66 0.4× 197 1.4× 87 0.6× 12 1.3k
Yasuo Aihara Japan 20 260 0.8× 318 1.9× 22 0.1× 129 0.9× 102 0.7× 95 1.2k
Naomi L. Baker Australia 21 591 1.7× 97 0.6× 40 0.2× 104 0.7× 295 2.1× 25 1.2k
Takeru Hamashima Japan 16 429 1.3× 117 0.7× 90 0.5× 83 0.6× 17 0.1× 37 995
Toomas Asser Estonia 18 232 0.7× 103 0.6× 75 0.5× 75 0.5× 20 0.1× 49 984
Yin-Cheng Huang Taiwan 17 355 1.0× 108 0.7× 34 0.2× 197 1.4× 84 0.6× 53 1.0k

Countries citing papers authored by Markus Vallaster

Since Specialization
Citations

This map shows the geographic impact of Markus Vallaster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Vallaster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Vallaster more than expected).

Fields of papers citing papers by Markus Vallaster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Vallaster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Vallaster. The network helps show where Markus Vallaster may publish in the future.

Co-authorship network of co-authors of Markus Vallaster

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Vallaster. A scholar is included among the top collaborators of Markus Vallaster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Vallaster. Markus Vallaster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
3.
Hoffmann, Michèle J., Xingyue He, Cheryl Black, et al.. (2023). Abstract A009: AFNT-111: A novel TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V. Molecular Cancer Research. 21(5_Supplement). A009–A009. 1 indexed citations
4.
Hoffmann, Michèle J., Martin Campbell, Klaus Pechhold, et al.. (2023). AFNT-211: An FAS-41BB–enhanced TCR-T cell therapy with stem-like properties targeting KRAS G12V-expressing solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 2543–2543. 1 indexed citations
5.
6.
He, Zhijian, Song Ren, Fred R. Rollins, et al.. (2022). A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies. Clinical Pharmacology in Drug Development. 11(10). 1130–1135. 3 indexed citations
7.
Chong, Curtis R., Todd M. Bauer, Scott A. Laurie, et al.. (2019). A phase Ia/Ib, open label, multicenter, dose-escalation study of BI 907828 (MDM2-p53 antagonist) in adult patients with advanced or metastatic solid tumors.. Journal of Clinical Oncology. 37(15_suppl). TPS3166–TPS3166. 3 indexed citations
8.
Vallaster, Markus, Shweta Kukreja, Xinyang Bing, et al.. (2017). Paternal nicotine exposure alters hepatic xenobiotic metabolism in offspring. eLife. 6. 54 indexed citations
9.
Shea, Jeremy M., Ryan W. Serra, Benjamin R. Carone, et al.. (2015). Genetic and Epigenetic Variation, but Not Diet, Shape the Sperm Methylome. Developmental Cell. 35(6). 750–758. 103 indexed citations
10.
Zhao-Shea, Rubing, Steven R. DeGroot, Liwang Liu, et al.. (2015). Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal. Nature Communications. 6(1). 6770–6770. 124 indexed citations
11.
Brunner, Stefan, Hans Theiß, Ulrich Grabmaier, et al.. (2013). Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy. Basic Research in Cardiology. 108(6). 388–388. 15 indexed citations
12.
Theiß, Hans, Lisa Groß, Markus Vallaster, et al.. (2013). Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. International Journal of Cardiology. 168(4). 3359–3369. 36 indexed citations
13.
Theiß, Hans, Markus Vallaster, Christoph Rischpler, et al.. (2011). Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis. Stem Cell Research. 7(3). 244–255. 97 indexed citations
14.
Zaruba, Marc‐Michael, Hans Theiß, Markus Vallaster, et al.. (2009). Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction. Cell stem cell. 4(4). 313–323. 249 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolyn M. Macica Breakdown of academic impact, for papers by Irene Szijan Breakdown of academic impact, for papers by Daisuke Kajimura Breakdown of academic impact, for papers by Ahmet Okay Çağlayan Breakdown of academic impact, for papers by Mei Fang Breakdown of academic impact, for papers by Yasuo Aihara Breakdown of academic impact, for papers by Naomi L. Baker Breakdown of academic impact, for papers by Takeru Hamashima Breakdown of academic impact, for papers by Toomas Asser Breakdown of academic impact, for papers by Yin-Cheng Huang
Rankless by CCL
2026